Rezultaty - Andrea Antinori
- Rezultaty 1 - 20 Rezultaty od 116
- Idź do następnej strony
-
1
EBV and HIV-Related Lymphoma od Michele Bibas, Andrea Antinori
Wydane 2009Artigo -
2
-
3
-
4
-
5
Patient With HIV-Associated Plasmablastic Lymphoma Responding to Bortezomib Alone and in Combination With Dexamethasone, Gemcitabine, Oxaliplatin, Cytarabine, and Pegfilgrastim Che... od Michele Bibas, Susanna Grisetti, Lucia Alba, Giovanna Picchi, Franca Del Nonno, Andrea Antinori
Wydane 2010Artigo -
6
-
7
-
8
A Genotypic Drug Resistance Interpretation Algorithm that Significantly Predicts Therapy Response in HIV-1-Infected Patients od Kristel Van Laethem, Andrea De Luca, Andrea Antinori, Antonella Cingolani, Carlo Federico Perno, Anne–Mieke Vandamme
Wydane 2002Artigo -
9
Minimally Invasive Diagnosis of Acquired Immunodeficiency Syndrome-Related Primary Central Nervous System Lymphoma od Antonella Cingolani, Andrea De Luca, Adriana Ammassari, Andrea Antinori, L Ortona, Luigi M. Larocca, Massimo Scerrati
Wydane 1998Artigo -
10
-
11
Efficacy of Cerebrospinal Fluid (CSF)–Penetrating Antiretroviral Drugs against HIV in the Neurological Compartment: Different Patterns of Phenotypic Resistance in CSF and Plasma od Andrea Antinori, Carlo Federico Perno, Maria Letizia Giancola, Federica Forbici, Giuseppe Ippolito, Richard M. W. Hoetelmans, Stephen C. Piscitelli
Wydane 2005Artigo -
12
Immune characterization of the HBHA-specific response in Mycobacterium tuberculosis-infected patients with or without HIV infection od Teresa Chiacchio, Giovanni Delogu, Valentina Vanini, Gilda Cuzzi, Flavio De Maio, Carmela Pinnetti, Alessandro Sampaolesi, Andrea Antinori, Delia Goletti
Wydane 2017Artigo -
13
Changes in Cognition During Antiretroviral Therapy: Comparison of 2 Different Ranking Systems to Measure Antiretroviral Drug Efficacy on HIV-Associated Neurocognitive Disorders od Valerio Tozzi, Pietro Balestra, Maria Flora Salvatori, Chrysoula Vlassi, Giuseppina Liuzzi, Maria Letizia Giancola, Marinella Giulianelli, Pasquale Narciso, Andrea Antinori
Wydane 2009Artigo -
14
Neurological and psychiatric tolerability of rilpivirine (<scp>TMC</scp>278) <i>vs.</i> efavirenz in treatment‐naïve, <scp>HIV</scp>‐1‐infected patients at 48 weeks od AM Mills, Andrea Antinori, Bonaventura Clotet, Jan Fourie, Gisella Herrera, Charles B. Hicks, JV Madruga, Simon Vanveggel, Marita Stevens, Katia Boven
Wydane 2013Artigo -
15
Plasma levels of interleukin-6 and interleukin-10 in preterm neonates evaluated for sepsis od Costantino Romagnoli, Simonetta Frezza, Antonella Cingolani, Andrea De Luca, Maria Puopolo, Maria Pia De Carolis, Giovanni Vento, Andrea Antinori, Giuseppe Tortorolo
Wydane 2001Artigo -
16
Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA) od Antonella Cingolani, Andrea Antinori, Maria Gabriella Rizzo, Rita Murri, Adriana Ammassari, Francesco Baldini, Simona Di Giambenedetto, Roberto Cauda, Andrea De Luca
Wydane 2002Artigo -
17
-
18
-
19
Multiple drug class-wide resistance associated with poorer survival after treatment failure in a cohort of HIV-infected patients od Mauro Zaccarelli, Valerio Tozzi, Patrizia Lorenzini, Maria Paola Trotta, Federica Forbici, Ubaldo Visco‐Comandini, Caterina Gori, Pasquale Narciso, Carlo Federico Perno, Andrea Antinori
Wydane 2005Artigo -
20
Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment od Giuseppe Lapadula, Alessandro Cozzi‐Lepri, Giulia Marchetti, Andrea Antinori, Alessandro Chiodera, Emanuele Nicastri, Giustino Parruti, Massimo Galli, Andrea Gori, Antonella d’Arminio Monforte
Wydane 2012Artigo
Narzędzie wyszukiwania:
Podobne hasła
Medicine
Internal medicine
Immunology
Virology
Human immunodeficiency virus (HIV)
Biology
Viral load
Disease
Antiretroviral therapy
Virus
Coronavirus disease 2019 (COVID-19)
Infectious disease (medical specialty)
Gene
Regimen
Biochemistry
Pathology
Environmental health
Immune system
Cohort
Confidence interval
Genetics
Population
Gastroenterology
Viral disease
Outbreak
Cohort study
Intensive care medicine
Hepatitis B virus
Pediatrics
Recombinant DNA